Brief: Xbrane Biopharma Q3 EBITDA Swings To Profit SEK 62.1 Million

Xbrane Biopharma AB

16/11/2018 07:08

Nov 16 (Reuters) - Xbrane Biopharma AB  XBRANE.ST :
    * Q3 EBITDA  SEK 62.1 MILLION VERSUS LOSS SEK 8.2 MILLION
YEAR AGO

Source text for Eikon:  ID:nGNEbnJCsF 
Further company coverage:  XBRANE.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))